Fungal diseases have garnered increased public awareness over the past decade or so but are still overlooked in comparison to viral and bacterial pathogens. When the average person thinks of a fungal disease they will probably picture ringworm, athletes foot, or yeast infections, usually pretty mild irritations.
What has been developing behind the scenes is a lot more concerning, though. We can talk about a few pathogenic fungi which are on the rise. The first is Candidozyma auris (formerly Candida auris), which has infected tens of thousands of people in 80+ countries across six continents with a 30-60% mortality rate.
The fungus is fond of warm, salty environments, including your groin and armpits (I'm fond too), but also plastic surfaces found in hospital wards like beds, tubing, handles, etc. It's resistant to standard hospital disinfectants and antifungals.
In England, there were five C. auris outbreaks in hospitals between April 2025 and September 2025. The C. auris strains in the UK are apparently still treatable but some found outside of the UK have started showing resistance to all antifungals.
This is part of the problem. Our overuse of antifungals, especially in agriculture (spraying crops) breeds resistance, and climate change forces adaptation to warmer (closer to body temperature) conditions and the potential for fungi to expand their range. C auris can in fact tolerate up to 41°C, well above body temperature.
Humans use about one million metric tons of fungicides and bactericides per year to prevent crop diseases and increase yields. The five big calorie staples of rice, maize, wheat, potatoes, and soybeans are all at elevated risk from fungal diseases.
Globally, farmers lose between 10-23% of their crops to fungal infection per year (*despite* heavy antifungal use), which is projected to worsen as climate change continues and new diseases move poleward.
Floods cause widespread decay and provide the moisture needed for spore growth. Wildfires aerosolize spores and carry them hundreds of miles. The likelihood of opportunistic soil fungi jumping hosts and infecting animals and humans continues to increase.
“We can’t simply stop using agricultural fungicides, because this would cause a famine, which would probably kill more people than fungal disease,” - Mr. Stephen Hughes, consultant antimicrobial pharmacist at the Chelsea Westminster Hospital NHS Foundation Trust.
Furthermore, thanks to modern medicine a steadily growing fraction of the population are able to survive with heavily diminished immune systems. Immunosuppresive drugs are essential for those suffering from countless autoimmune conditions, organ transplants, and certain cancer treatments. Sometimes people are just naturally compromised due to age or disease.
These people are incredibly vulnerable to infections and act as human incubators for new fungal diseases. Especially those undergoing invasive treatments such as heart-lung machines, ventilators, catheters and such which allow fungi to enter deeply into body cavities and tissues.
Pathogenic fungi can also form biofilms inside the body that act as infectious reservoirs for recurrent illness. Biofilms are communities of fungal cells embedded in an extracellular matrix of carbohydrates, proteins, and nucleic acids.
These can form on internal medical devices: artifical heart valves, catheters, pacemakers, etc. Fungal balls (such as aspergillomas) can form in the lungs. Cryptococcus can form biofilm-like clusters that enter the brain through ventriculoatrial shunts. Biofilms can persist in the oral and vaginal epithelium.
In those with diminished immune activity these infections can become chronic, often leading to fungus invading the bloodstream (fungaemia), organs, and bones (osteomyelitis).
As these people are reliant on prolonged, repeated antifungal treatments to survive, this creates more opportunities for resistant strains to emerge in the body and becoming "pan-resistant" to multiple antifungals.
C. auris used to be seen in mostly immunocompromised people but it is now regularly infecting normal people. There was a woman with a vaginal infevtion caused by C. auris. Typically a vaginal yeast infection would be treated with an azole based pill or suppository and be done with, but in this case she needed a IV antifungal over the course of days to shift it. It is also causing UTIs. It is likely to become something akin to MRSA, but the fungal equivalent.
But that's not all! No, C. auris is far from the only concerning fungal disease. Valley fever (coccidioidomycosis) is a fairly well known soil-based, dust-borne fungal lung infection that infects some 360k people in the US per year and was historically primarily confined to the hot, desert southwest (arizona, california, nevada etc) but has since spread out. Including to Washington which was historically too wet and cool to harbor such a pathogen.
It is commonly misdiagnosed as colds or other common infections, even where its endemic. And as it's in the dirt, you can breathe it in anywhere. If your body fails to clear it, it can become a permanent pneumonic disease, or in some cases a disseminated infection that spreads out from the lungs causing skin sores and joint, bone, and brain problems, eating away at bone and causing lesions.
Another one, ringworm, a widely known and easily treated skin infection that many of us have had is also now a concern. A new type of ringworm that is resistant to all antifungal drugs has spread from India to the Middle East, Europe, and the USA.
This new highly contagious ringworm evolved due to the overuse of OTC antifungal meds and is likely to become the predominant ringworm found globally within the next decade. It causes chronic, angry skin plaques all over the body. “Think of athlete’s foot, but it’s now athlete’s body, and it’s untreatable,” - Dr. Tom Chiller, infectious disease specialist.
There is even a newly emerging sexually transmitted fungal infection, known as Trichophyton mentagrophytes type VII (TMVII). It causes similar ringworm placques on the genitals, mouth, perineum.
It has been spreading among men who have sex with men, and those who have visited sex workers in southeast Asia. Be safe with the ladyboys, guys. But it also spreads through fomites such as towels, sex toys, bedding, etc. It's been in the US since 2024 and Europe for a few years before that. This ones still treatable for now it seems, with 6-12 weeks of oral terbinafine, but STIs are notorious for creating superbugs.
Then there is Sporothrix brasiliensis, a fungus endemic to Brazil which first became widely known during a 1998 outbreak in Rio de Janeiro, whereby sickened and disfigured cats were turning up to vet clinics, but it soon began spreading to dogs and humans likely through infected scratches, bites, and sneezes.
S. brasiliensis leaves disfiguring, darkened scars across the face and body. In around 10% of cases, often the immunocompromised, it will enter the body and infect the bones, brain, and lungs. From 1998 to 2001, some 180 humans were infected, but now it is thousands annually. It has also continued to spread into remote Amazonian villages, and into Argentina, Chile, Paraguay, Panama, and elsewhere.
The arsenal of antifungals is small, with three main classes: azoles, polyenes, and echinocandins. The two former target the cell membrane and the latter the cell wall.
They also unfortunately carry significant off-target effects due to the many similarities between fungal and human cells which makes toxicity problematic. Azoles, for instance, cause issues with hepatotoxicity (liver injury) and polyenes with nephrotoxicity (kidney injury).
Sometimes it is easy to see where resistance originates from. For example, Aspergillus fumigatus is a mould found commonly in compost and decaying plant matter.
In the UK, A. fumigatus is exposed to the azole fungicides commonly used on crops, and has developed resistance to it. This mould can easily survive at 37°C due to it living in thermophilic compost environments.
You breathe in the spores, you may get sick with aspergillosis and now you have an azole-resistant infection despite never taking azole antifungals in your life.
In the Netherlands, extremely heavy use of fungicides in the flower bulb industry has forced a high rate of azole-resistant A. fumigatus to develop. Now the standard treatment combines an azole agent with an echinocandin.
However, all is not lost. Quite a number of new drugs have been under development including ibrexafungerp, Fosmanogepix, olorofim and others (no, I did not make up those names) which target the fungal cell in different ways.
Something to bear in mind, though, is whilst olorofim is currently going through clinical trials for human medical use, a slightly different chemical with the same mechanism of action has already been approved for agricultural use in the US so these drugs are already being compromised before they've even been given a chance. That is the precarious balance is between human health and crop survival.
The rising cost of developing new drugs is also limiting the ability to find treatments for these infections. The fact that commercial interest in new antifungals has been plateauing whilst pathogenic fungi are simultaneously evolving resistance to all licenced systemic antifungal drugs is bad news to say the least.
AI is likely to accelerate research and discovery of novel antifungals going forward, so at least there's that. Look after your immune systems. Don't use fungicides in your garden. Be careful turning compost piles without a mask. Ensure your house does not have mould problems. Not sure there's much else you can do tbh.
Sorry, this is a long post. I kept adding info as I read more about the topic. I wanted to talk more about the agricultural side but it would be way longer and nobody will read this anyway. Also I am partially blind right now with some visual auras so I can't see what I'm doing. Happy Friday.
Sources: